This month in @Pharmaphorum, @Spitz summarizes the recent US House of Representative hearings regarding mobile medical device guidance, discusses implications, and shares some best practices for implementation. Read how even the final guidance will likely open the door to even more questions than it answers, while still providing a framework from which the industry can start to move forward with confidence.
Share your own thoughts and feedback below!
